Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell surface expression of HLA-E: interaction with human beta2-microglobulin and allelic differences.

M Ulbrecht1, A Couturier, S Martinozzi

  • 1Institut für Anthropologie und Humangenetik, Ludwig-Maximillians-Universität München, Germany.

European Journal of Immunology
|March 4, 1999
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional and anatomic outcomes of brolucizumab in adults with neovascular age-related macular degeneration - The OCTOPUS cohort study.

Journal francais d'ophtalmologie·2025
Same author

Disease control, visual and anatomic outcomes at week 48 of brolucizumab treatment in patients with previously suboptimal anatomically controlled neovascular age-related macular degeneration - The SWIFT study.

Journal francais d'ophtalmologie·2025
Same author

Spatially resolved imaging of human macular capillaries using adaptive optics-enhanced optical coherence tomography angiography.

Scientific reports·2024
Same author

Relationship between obsessive compulsive symptomatology and severity of psychotic symptoms in schizophrenia: Meta-analysis and meta-regression analysis.

Schizophrenia research·2022
Same author

[Treatment of exudative age-related macular degeneration: Consensus of French experts for first-line treatment selection and the importance of long-term risk/benefit ratio].

Journal francais d'ophtalmologie·2021
Same author

[Treatment switch in diabetic macular edema: Literature review and management algorithm].

Journal francais d'ophtalmologie·2020

Cell surface expression of HLA-E requires beta2-microglobulin (beta2m) coexpression. Allelic variations at position 107 significantly impact HLA-E transport and expression, suggesting low affinity interactions affect peptide loading.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • MHC class I molecule assembly, including heavy chain, beta2-microglobulin (beta2m), and peptide ligand, is crucial for cell surface transport.
  • Previous studies showed impaired intracellular transport of human HLA-E in mouse cells, likely due to inefficient peptide loading.

Purpose of the Study:

  • To investigate the dependence of HLA-E cell surface expression on beta2m coexpression.
  • To assess the impact of beta2m interaction affinity on HLA-E peptide loading and transport.
  • To evaluate the effect of HLA-E allelic variation on intracellular transport and cell surface expression.

Main Methods:

  • Transfection of mouse myeloma X63 cells with HLA-E and human beta2m (hbeta2m) genes.
  • Analysis of cell surface expression of HLA-E.

Related Experiment Videos

  • Assessment of thermostability of soluble HLA-E/hbeta2m complexes.
  • Introduction of specific HLA-E allelic variations (Gly/Arg at position 107) via transfection.
  • Main Results:

    • Cell surface expression of HLA-E in mouse cells is strictly dependent on hbeta2m coexpression.
    • Soluble empty HLA-E/hbeta2m complexes exhibit low thermostability, indicating weak interactions.
    • Low affinity interaction between HLA-E and beta2m contributes to inefficient peptide uptake in the endoplasmic reticulum.
    • An allelic variation at amino acid position 107 (Gly vs. Arg) significantly affects HLA-E intracellular transport and cell surface expression.

    Conclusions:

    • Coexpression of hbeta2m is essential for cell surface expression of HLA-E.
    • The low affinity of HLA-E for beta2m is a key factor limiting peptide loading and transport.
    • Allelic variations in HLA-E, particularly at position 107, critically influence its trafficking and surface presentation, independent of peptide ligand sequence.